RICHMOND, Calif., April 24, 2017 /PRNewswire/ -- Sangamo
Therapeutics, Inc. (Nasdaq: SGMO), the leader in therapeutic genome
editing, announced today that Dr. Sandy
Macrae, Sangamo's chief executive officer, will provide a
corporate overview at the Alliance for Regenerative Medicine's
5th Annual Cell & Gene Therapy Investor Day on
Thursday, April 27th at
2:30 p.m. Eastern Time. The meeting
is being held in Boston, MA.
The presentation and discussion will be webcast live and may be
accessed via a link on the Sangamo Therapeutics website in the
Investor Relations section under Events and Presentation. A live
video webcast of the presentation will also be available at
http://www.arminvestorday.com/webcast. The presentation will be
archived on the Sangamo website for two weeks once the replay of
the event is available.
About Sangamo Therapeutics
Sangamo Therapeutics, Inc.
is focused on translating ground-breaking science into genomic
therapies that transform patients' lives using the company's
industry leading platform technologies in genome editing, gene
therapy, gene regulation and cell therapy. For more information
about Sangamo, visit the Company's website at www.sangamo.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/sangamo-therapeutics-announces-participation-in-the-arm-5th-annual-cell--gene-therapy-investor-day-300444504.html
SOURCE Sangamo Therapeutics, Inc.